drugset / Trial / NCT03117322

Synbiotic, Prebiotics and Probiotics in Children With Cerebral Palsy and Constipation

NCT03117322

Phase 4 Completed 40 enrolled Andrea Garcia Contreras
RandomizedFactorialTriple-blindTreatment

Summary

Randomized double blind controlled clinical trial. Participants will be enrolled at the New Civil Hospital of Guadalajara "Dr. Juan I. Menchaca" during the period from May 2017 to July 2018, from six to 59 months of either sex. The duration of each participant in the study will be of four weeks. Each participant will be randomized assigned to any of the different study groups: synbiotic, prebiotic, probiotic or placebo. Hypothesis: The efficacy of supplementation with a symbiotic, a prebiotic and a probiotic differs in its beneficial effect on the intestinal microbiota and the characteristics of feces in children with CP and chronic constipation.

Timeline

Start
2017-06-05
Primary completion
2018-12-21
Completion
2018-12-21

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Lactobacillus reuteri DSM 17938 Other / unclassified 1e+08 unknown
Subject agave inulin Unknown 4 g